| JXSB2101033 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-07-13 | | Eli Lilly & Company | | | view |
| JXSL1900094 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products | Import Drug Application | 2019-09-23 | | Eli Lilly & Company | In Review | 2019-09-21 | view |
| JXSB2300051 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2023-05-05 | | Eli Lilly & Company | | | view |
| JXSB2101069 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-10-21 | | Eli Lilly & Company | | | view |
| JXSL1900014 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products | Import Drug Application | 2019-02-18 | | Eli Lilly & Company | In Review | 2019-02-16 | view |
| JXSB2200083 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-06-20 | | Eli Lilly & Company | | | view |
| JXSL2000073 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products | Import Drug Application | 2020-06-10 | | Eli Lilly & Company | In Review | 2020-06-09 | view |
| JXSB2400162 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-11-29 | | Eli Lilly & Company | | | view |
| JXSB2101110 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-12-16 | | Eli Lilly & Company | | | view |
| JXSL1900093 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products | Import Drug Application | 2019-09-23 | | Eli Lilly & Company | In Review | 2019-09-21 | view |
| JXSB2200082 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-06-20 | | Eli Lilly & Company | | | view |
| JXSB2200110 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-09-06 | | Eli Lilly & Company | | | view |
| JXSB2101070 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-10-21 | | Eli Lilly & Company | | | view |
| JXSL2000075 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products | Import Drug Application | 2020-06-10 | | Eli Lilly & Company | In Review | 2020-06-09 | view |
| JXSB2300069 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2023-06-07 | | Eli Lilly & Company | | | view |
| JXSB2200108 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-09-06 | | Eli Lilly & Company | | | view |
| JXSB2400161 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-11-29 | | Eli Lilly & Company | | | view |
| JXSB2101111 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-12-16 | | Eli Lilly & Company | | | view |
| JXSB2200109 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-09-06 | | Eli Lilly & Company | | | view |
| JXSL2000074 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products | Import Drug Application | 2020-06-10 | | Eli Lilly & Company | In Review | 2020-06-09 | view |
